Growth Metrics

Jazz Pharmaceuticals (JAZZ) Cash from Investing Activities Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 116.52%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 38.24%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -22.09%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 30.54%
10 Jazz Pharmaceuticals 14.64 Bn 12.79 Bn 934.80 Mn 201.95%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 201.95%
Dec 31, 2025 -4.69%
Sep 30, 2025 -318.37%
Jun 30, 2025 -93.00%
Mar 31, 2025 -65.48%
Dec 31, 2024 -167.55%
Sep 30, 2024 115.33%
Jun 30, 2024 64.84%
Mar 31, 2024 -33.31%
Dec 31, 2023 11.61%
Sep 30, 2023 14.58%
Jun 30, 2023 51.27%
Mar 31, 2023 56.86%
Dec 31, 2022 -26.81%
Sep 30, 2022 26.59%
Jun 30, 2022 -223.32%
Mar 31, 2022 -30.54%
Dec 31, 2021 -31.08%
Sep 30, 2021 48.10%
Jun 30, 2021 -214.21%
Mar 31, 2021 152.69%
Dec 31, 2020 62.57%
Sep 30, 2020 -11.20%
Jun 30, 2020 -190.76%
Mar 31, 2020 -156.17%
Dec 31, 2019 -340.64%
Sep 30, 2019 52.93%
Jun 30, 2019 76.61%
Mar 31, 2019 151.16%
Dec 31, 2018 140.31%
Sep 30, 2018 -233.72%
Jun 30, 2018 -151.21%
Mar 31, 2018 -69.28%
Dec 31, 2017 -31.02%
Sep 30, 2017 -34.73%
Jun 30, 2017 -31.92%
Mar 31, 2017 84.49%
Sep 30, 2016 -388.15%
Jun 30, 2016 -174.16%
Mar 31, 2016 -23.02%
Dec 31, 2015 -26.80%
Sep 30, 2015 -11.23%
Jun 30, 2015 72.23%
Mar 31, 2015 -39.48%
Dec 31, 2014 39.99%
Sep 30, 2014 -82.75%
Jun 30, 2014 -152.07%
Mar 31, 2014 -829.75%
Sep 30, 2013 -153.70%